| Literature DB >> 35694174 |
Ricardo Vejarano1, Mariano Luján-Corro2.
Abstract
There is ample evidence regarding the health benefits of red wine consumption due to its content of phenolic compounds, as an alternative to improve the state of health and prevent various diseases, being the implementation of procedures that allow a greater extraction and stability of phenolic compounds during the elaboration a key aspect. The first part of this review summarizes some studies, mostly at the preclinical level, on the mechanisms by which phenolic compounds act in the human organism, taking advantage of their antioxidant, anti-inflammatory, antitumor, antithrombotic, antiatherogenic, antimicrobial, antiviral, and other activities. Although the migration of grape components into the must/wine occurs during the winemaking process, the application of new technologies may contribute to increasing the content of phenolic compounds in the finished wine. Some of these technologies have been evaluated on an industrial scale, and in some cases, they have been included in the International Code of Oenological Practice by the International Organization of Vine and Wine (OIV). In this sense, the second part of this review deals with the use of these novel technologies that can increase, or at least maintain, the polyphenol content. For example, in the pre-fermentative stage, phenolic extraction can be increased by treating the berries or must with high pressures, pulsed electric fields (PEF), ultrasound (US), e-beam radiation or ozone. At fermentative level, yeasts with high production of pyranoanthocyanins and/or their precursor molecules, low polyphenol absorption, and low anthocyanin-β-glucosidase activity can be used. Whereas, at the post-fermentative level, aging-on-lees (AOL) can contribute to maintaining polyphenol levels, and therefore transmitting health benefits to the consumer.Entities:
Keywords: anti-inflammatory; antioxidant; disease prevention; emerging technologies; extraction; polyphenols; red wine
Year: 2022 PMID: 35694174 PMCID: PMC9174943 DOI: 10.3389/fnut.2022.890066
Source DB: PubMed Journal: Front Nutr ISSN: 2296-861X
FIGURE 1Main involved mechanisms in the antioxidant and anti-inflammatory activities of the phenolic compounds of red wine.
Some clinical studies on the effect of red wine on biomarkers of cardiovascular risk and related pathologies.
| Volunteers | Red wine doses | Main results | References |
| 19 women and 21 men | 125 mL/day (women) and 250 mL/day (men) | Higher total antioxidant capacity | ( |
| 52,367 women and 97,406 men | Equivalent to 10–30 g/day of ethanol | Higher total antioxidant capacity | ( |
| 1,896 men | Equivalent to 26.7 g/day of ethanol | Higher HDL levels | ( |
| 10 men | Daily doses of 272 mL of red wine, or 272 mL of non-alcoholic red wine, or 100 mL of gin | Lower blood pressure | ( |
| 35 women | 1 glass of red wine or white wine, equivalent to 20 g/day of ethanol | Higher HDL levels | ( |
| 23,349 (women and men) | Equivalent to 10–50 g/day of ethanol in men, and 5–25 g/day in women. | Lower mortality with the Mediterranean diet, with red wine contributing to this effect by 23.5%. | ( |
FIGURE 2Main cardioprotective and neuroprotective effects of the phenolic compounds of red wine.
FIGURE 3Technological strategies to improve the content of phenolic compounds during red winemaking.
Applications of high-pressure technologies to improve the extraction of phenolic compounds during red winemaking.
| High pressure technology | Sample (volume) | Operation parameters | Main results respect to control treatment | Reference |
| Red grape berries | 200 MPa, 10 min, < 30°C | ( | ||
| Red grape by-products | 600 MPa, 60 min, 70°C | •↑ total phenolic content (> 1.5-fold higher) | ( | |
| Red wine | 350 MPa, 10 min, 8°C | Wines with < 60 mg/L SO2 (6 months of storage): | ( | |
| Red grape must | 300 MPa, 77°C, < 0.2 s | ( |
*Oxidative process: monitored by the evolution of the hue (evolution from red-blue to red-brown tonalities).
Applications of pulsed electric fields to improve the extraction of phenolic compounds during red winemaking.
| Technology | Sample (volume) | Operation parameters | Main results respect to control treatment | References |
| Red grape must (Garnacha, Mazuelo, and Graciano) | 2–10 kV cm–1, 0.4–6.7 kJ kg–1, | ( | ||
| Red grape must | 2–7 kV cm–1, 0.56–6.76 kJ kg–1, 50 pulses, pulse width 3 μs, 0.41 s, 122 Hz, < 23°C | ( | ||
| Red grape must | 4 kV cm–1, 1.5 kJ kg–1, 20 pulses, pulse width 3 μs, 60 μs, 0.41 s, 250 Hz | ( | ||
| Red grape must (Pinot Noir) | 1.5 kV cm–1, 14.48 and 69.99 kJ kg–1, 243 and 1,033 pulses, pulse width 20 μs, 50 Hz, < 25°C | • Maximum extraction of malvidin-3-O-glucoside (224% higher) after 8 days of maceration | ( | |
| Red grape must | 7 kV cm–1, 178 Hz | ( | ||
| Red grape must | 0.7–7.8 kV cm–1, 78–5,000 μs, 12–290 Hz | ( | ||
| Red grape must | 33.1–41.5 kV cm–1, 4.7–49.4 kJ L–1, 2–25 Hz | ( | ||
| Red grape must (Sangiovese) | 0.9–3.0 kV cm–1, 10.4–32.5 kJ kg–1, 712–1,069 pulses, 0.48–0.71 s, 1,500 Hz | ( | ||
| Red grape must | 1.5 kV cm–1, 2–20 kJ L–1, pulse width 3 μs, 400 Hz | ( | ||
| Red grape must | 4.3 kV cm–1, 6.2 kJ kg–1, 3.7 square pulses of 100 μs | ( | ||
| Red grape must | 5–17.5 kV cm–1, 63.4–115 kJ kg–1, 45 pulses, 0.38–0.24 s, 120 kg/h | ( | ||
| Red grape pomace | 3 kV cm–1, 10 kJ kg–1, 30 pulses, 15 s, 2 Hz, | •↑ total phenolic content (> 1.5-fold higher) | ( |
*Results respect to control for each treatment (without PEF application). dm, dynamic maceration 2 h; sm, static maceration 12 h.
** Oxidative process: monitored by the evolution of the hue (evolution from red-blue to red-brown tonalities).
Applications of ultrasound and irradiation to improve the extraction of phenolic compounds during red winemaking.
| Technology | Sample (volume) | Operation parameters | Main results respect to control treatment | Reference |
|
| Red grape berries | 40 Hz, 280 W, 90 min, 18°C | ( | |
|
| Red grape berries | 28 kHz, 2,500 W, 8 W cm–2 | ( | |
|
| Red grape pomace | 35 KHz, 60 min, 70°C | •↑ total phenolic content (> 1.5-fold higher) | ( |
|
| Red grape pomace | Bath mode: 50–100 W, 50 min, 30°C | ( | |
|
| Red grape berries | 0.5–2 kGy | ( | |
| Red grape berries | 0.5–10 kGy, | • | ( | |
|
| Red grape berries | ( | ||
|
| Red grape berries | 1.2 g/h of O3 for 12 h at 4°C | ( | |
|
| Red grape berries | 30 μL/L at 20°C | ( |
Strategies applied at the fermentative level and during the aging of red wines to improve and/or maintain the content of phenolic compounds.
| Winemaking stage | Technological strategy | Wine | Main results respect to control treatment | References |
|
| Syrah | ( | ||
| Tempranillo | ↑ Total anthocyanins (> 1.6 respect to AF + MLF) | ( | ||
| Addition of mannoprotein before fermentation | Cabernet Sauvignon | •↑ Total polyphenols content (up to 1.2-fold higher) | ( | |
|
| Application of AOL | Tempranillo | Maintains the total anthocyanins content | ( |
| Addition of mannoprotein during storage | Cabernet Sauvignon | ↑ Cyanidin-3,5-O-diglucoside (up to 10.8-fold higher) | ( |
AF + MLF: traditional winemaking process involving alcoholic fermentation (AF) + malolactic fermentation (MLF).